Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$277,678
+$133,662 QoQ
Shares Held
59,716
+123.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. AVIR ranks #225 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,678 | 59,716 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $144,016 | 26,769 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $284,864 | 79,794 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $170,731 | 58,873 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $177,440 | 49,289 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $138,777 | 46,414 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $152,059 | 45,391 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $119,012 | 35,526 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $113,711 | 34,354 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $111,257 | 27,539 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $73,394 | 24,064 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $58,356 | 19,452 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $111,081 | 29,701 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $47,114 | 14,064 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,405 | 500 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,954 | 695 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,350 | 1,317 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $219,004 | 30,333 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $462,760 | 51,763 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,877,067 | 281,719 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,971 | 278 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $281,950 | 4,566 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $315,940 | 7,562 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||